DMNQ induces ferroptosis and augments the efficacy of anti-PD-L1 immunotherapy in gastric cancer via the STAT3/SLC1A4 axis to mediate cysteine metabolism reprogramming
Wenshuai Zhu, He Qi, Fubo Jing, Yuxuan Shi, Yuanxin Xing, Xiaoli Ma, Bin Ning, Yunshan Wang, Yanfei Jia
TL;DR
DMNQ causes cell death in stomach cancer cells and improves immunotherapy by targeting a specific pathway that controls cysteine metabolism.
Contribution
DMNQ induces ferroptosis and enhances anti-PD-L1 immunotherapy via the STAT3/SLC1A4 axis in gastric cancer.
Findings
DMNQ inhibits STAT3 phosphorylation and transcriptional activity to induce ferroptosis in gastric cancer cells.
The STAT3/SLC1A4 axis regulates cysteine uptake and enhances anti-PD-L1 immunotherapy efficacy.
DMNQ boosts anti-tumor effects when combined with anti-PD-L1 immunotherapy in gastric cancer.
Abstract
Ferroptosis plays an essential role in tumor progression. Therapeutic agents targeting ferroptosis emerge as a novel strategy for cancer treatment. Abnormal amino acid metabolism can control ferroptosis sensitivity in cancer cells, and lead to the deficiency or accumulation of specific products in the tumor microenvironment (TME). Here, we demonstrated that 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) induced growth inhibition in gastric cancer cell lines, primary gastric cancer mouse models, and patient-derived tumor organoids. DMNQ exerted ferroptosis inducing effects by inhibiting STAT3 phosphorylation and transcriptional activity. Importantly, the STAT3/SLC1A4 axis regulated cysteine uptake, tumor killing by T cells and the efficacy of anti-PD-L1 immunotherapy. Collectively, our findings revealed a critical mechanism by which DMNQ exerts a significant anti-cancer role in gastric cancer…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFerroptosis and cancer prognosis · Immune cells in cancer · Bladder and Urothelial Cancer Treatments